vs

Side-by-side financial comparison of CENTERSPACE (CSR) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $66.6M, roughly 1.9× CENTERSPACE). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 0.3%). CENTERSPACE produced more free cash flow last quarter ($64.3M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 1.6%).

Centerspace is a real estate investment company specializing in the ownership, operation, and development of high-quality multifamily residential properties. Its core operating markets cover the U.S. Midwest and Mountain West regions, serving diverse renter segments with both affordable and premium housing options, while focusing on tenant experience and long-term asset value growth.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

CSR vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.9× larger
ZLAB
$127.1M
$66.6M
CSR
Growing faster (revenue YoY)
ZLAB
ZLAB
+16.8% gap
ZLAB
17.1%
0.3%
CSR
More free cash flow
CSR
CSR
$91.0M more FCF
CSR
$64.3M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
1.6%
CSR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSR
CSR
ZLAB
ZLAB
Revenue
$66.6M
$127.1M
Net Profit
$-18.4M
Gross Margin
96.5%
51.0%
Operating Margin
-15.9%
-54.6%
Net Margin
-27.7%
Revenue YoY
0.3%
17.1%
Net Profit YoY
-262.9%
EPS (diluted)
$-1.08
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSR
CSR
ZLAB
ZLAB
Q4 25
$66.6M
$127.1M
Q3 25
$71.4M
$115.4M
Q2 25
$68.5M
$109.1M
Q1 25
$67.1M
$105.7M
Q4 24
$66.4M
$108.5M
Q3 24
$65.0M
$101.8M
Q2 24
$65.0M
$100.1M
Q1 24
$64.5M
$87.1M
Net Profit
CSR
CSR
ZLAB
ZLAB
Q4 25
$-18.4M
Q3 25
$53.8M
$-36.0M
Q2 25
$-14.5M
$-40.7M
Q1 25
$-3.7M
$-48.4M
Q4 24
$-5.1M
Q3 24
$-1.0M
$-41.7M
Q2 24
$-1.3M
$-80.3M
Q1 24
$-3.9M
$-53.5M
Gross Margin
CSR
CSR
ZLAB
ZLAB
Q4 25
96.5%
51.0%
Q3 25
96.5%
59.5%
Q2 25
96.5%
60.6%
Q1 25
96.4%
63.6%
Q4 24
96.5%
61.5%
Q3 24
96.6%
64.1%
Q2 24
96.6%
64.9%
Q1 24
96.4%
61.4%
Operating Margin
CSR
CSR
ZLAB
ZLAB
Q4 25
-15.9%
-54.6%
Q3 25
-42.3%
Q2 25
-9.9%
-50.3%
Q1 25
7.1%
-53.3%
Q4 24
4.3%
-62.6%
Q3 24
9.8%
-66.6%
Q2 24
11.1%
-76.0%
Q1 24
6.3%
-80.7%
Net Margin
CSR
CSR
ZLAB
ZLAB
Q4 25
-27.7%
Q3 25
75.3%
-31.2%
Q2 25
-21.2%
-37.3%
Q1 25
-5.6%
-45.8%
Q4 24
-7.6%
Q3 24
-1.6%
-40.9%
Q2 24
-2.0%
-80.2%
Q1 24
-6.1%
-61.4%
EPS (diluted)
CSR
CSR
ZLAB
ZLAB
Q4 25
$-1.08
$-0.05
Q3 25
$3.19
$-0.03
Q2 25
$-0.87
$-0.04
Q1 25
$-0.22
$-0.04
Q4 24
$-0.31
$-0.09
Q3 24
$-0.40
$-0.04
Q2 24
$-0.19
$-0.08
Q1 24
$-0.37
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSR
CSR
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$12.8M
$689.6M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$719.2M
$715.5M
Total Assets
$1.9B
$1.2B
Debt / EquityLower = less leverage
1.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSR
CSR
ZLAB
ZLAB
Q4 25
$12.8M
$689.6M
Q3 25
$12.9M
$717.2M
Q2 25
$12.4M
$732.2M
Q1 25
$11.9M
$757.3M
Q4 24
$12.0M
$779.7M
Q3 24
$14.5M
$616.1M
Q2 24
$14.3M
$630.0M
Q1 24
$12.7M
$650.8M
Total Debt
CSR
CSR
ZLAB
ZLAB
Q4 25
$1.0B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$955.5M
Q4 24
$955.4M
Q3 24
$921.3M
Q2 24
$931.7M
Q1 24
$929.1M
Stockholders' Equity
CSR
CSR
ZLAB
ZLAB
Q4 25
$719.2M
$715.5M
Q3 25
$748.6M
$759.9M
Q2 25
$710.1M
$791.7M
Q1 25
$636.8M
$810.8M
Q4 24
$752.0M
$840.9M
Q3 24
$672.5M
$667.7M
Q2 24
$680.7M
$704.2M
Q1 24
$688.1M
$762.2M
Total Assets
CSR
CSR
ZLAB
ZLAB
Q4 25
$1.9B
$1.2B
Q3 25
$2.1B
$1.2B
Q2 25
$2.0B
$1.2B
Q1 25
$1.9B
$1.2B
Q4 24
$1.9B
$1.2B
Q3 24
$1.9B
$985.3M
Q2 24
$1.9B
$987.4M
Q1 24
$1.9B
$988.4M
Debt / Equity
CSR
CSR
ZLAB
ZLAB
Q4 25
1.42×
Q3 25
1.53×
Q2 25
1.57×
Q1 25
1.50×
Q4 24
1.27×
Q3 24
1.37×
Q2 24
1.37×
Q1 24
1.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSR
CSR
ZLAB
ZLAB
Operating Cash FlowLast quarter
$98.5M
$-26.0M
Free Cash FlowOCF − Capex
$64.3M
$-26.7M
FCF MarginFCF / Revenue
96.5%
-21.0%
Capex IntensityCapex / Revenue
51.3%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$125.9M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSR
CSR
ZLAB
ZLAB
Q4 25
$98.5M
$-26.0M
Q3 25
$35.1M
$-32.0M
Q2 25
$25.3M
$-31.0M
Q1 25
$25.4M
$-61.7M
Q4 24
$98.2M
$-55.8M
Q3 24
$32.3M
$-26.8M
Q2 24
$22.9M
$-42.2M
Q1 24
$24.4M
$-90.1M
Free Cash Flow
CSR
CSR
ZLAB
ZLAB
Q4 25
$64.3M
$-26.7M
Q3 25
$25.7M
$-35.0M
Q2 25
$15.5M
$-33.9M
Q1 25
$20.4M
$-63.2M
Q4 24
$41.6M
$-58.4M
Q3 24
$20.5M
$-28.2M
Q2 24
$9.1M
$-42.9M
Q1 24
$2.6M
$-91.1M
FCF Margin
CSR
CSR
ZLAB
ZLAB
Q4 25
96.5%
-21.0%
Q3 25
36.0%
-30.4%
Q2 25
22.7%
-31.1%
Q1 25
30.4%
-59.9%
Q4 24
62.6%
-53.8%
Q3 24
31.5%
-27.7%
Q2 24
14.0%
-42.9%
Q1 24
4.0%
-104.5%
Capex Intensity
CSR
CSR
ZLAB
ZLAB
Q4 25
51.3%
0.5%
Q3 25
13.1%
2.6%
Q2 25
14.2%
2.6%
Q1 25
7.5%
1.5%
Q4 24
85.3%
2.4%
Q3 24
18.2%
1.3%
Q2 24
21.2%
0.7%
Q1 24
33.8%
1.1%
Cash Conversion
CSR
CSR
ZLAB
ZLAB
Q4 25
Q3 25
0.65×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSR
CSR

Multi Family Residential$57.3M86%
Other$8.1M12%
Other Property Revenue$1.2M2%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons